Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

Index by author

February 1, 2022; Volume 63,Issue 2
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. Maass-moreno, Roberto

    1. You have access
      Reply: On Semiquantitative Methods for Assessing Vascular 18F-FDG PET Activity in Large-Vessel Vasculitis
      Mark A. Ahlman, Roberto Maass-Moreno and Peter C. Grayson
      Journal of Nuclear Medicine February 1, 2022, 63 (2) 326; DOI: https://doi.org/10.2967/jnumed.121.263158
  2. Maimon, Ophra

    1. Efficacy and Safety of <sup>177</sup>Lu-DOTATATE in Lung Neuroendocrine Tumors: A Bicenter study
      You have access
      Efficacy and Safety of 177Lu-DOTATATE in Lung Neuroendocrine Tumors: A Bicenter study
      Lamiaa Zidan, Amir Iravani, Kira Oleinikov, Simona Ben-Haim, David J. Gross, Amichay Meirovitz, Ophra Maimon, Tim Akhurst, Michael Michael, Rodney J. Hicks, Simona Grozinsky-Glasberg and Grace Kong
      Journal of Nuclear Medicine February 1, 2022, 63 (2) 218-225; DOI: https://doi.org/10.2967/jnumed.120.260760
  3. Markowski, Mark C.

    1. The European Association of Urology Biochemical Recurrence Risk Groups Predict Findings on PSMA PET in Patients with Biochemically Recurrent Prostate Cancer After Radical Prostatectomy
      You have access
      The European Association of Urology Biochemical Recurrence Risk Groups Predict Findings on PSMA PET in Patients with Biochemically Recurrent Prostate Cancer After Radical Prostatectomy
      Liang Dong, Yun Su, Yinjie Zhu, Mark C. Markowski, Mei Xin, Michael A. Gorin, Baijun Dong, Jiahua Pan, Martin G. Pomper, Jianjun Liu, Kenneth J. Pienta, Wei Xue and Steven P. Rowe
      Journal of Nuclear Medicine February 1, 2022, 63 (2) 248-252; DOI: https://doi.org/10.2967/jnumed.121.262411
  4. Marthan, Roger

    1. You have access
      On Semiquantitative Methods for Assessing Vascular 18F-FDG PET Activity in Large-Vessel Vasculitis
      Eric Laffon and Roger Marthan
      Journal of Nuclear Medicine February 1, 2022, 63 (2) 325-326; DOI: https://doi.org/10.2967/jnumed.121.263060
  5. Massoumzadeh, Parinaz

    1. Dynamic Amyloid PET: Relationships to <sup>18</sup>F-Flortaucipir Tau PET Measures
      You have access
      Dynamic Amyloid PET: Relationships to 18F-Flortaucipir Tau PET Measures
      Fabio Raman, Yu-Hua Dean Fang, Sameera Grandhi, Charles F. Murchison, Richard E. Kennedy, John C. Morris, Parinaz Massoumzadeh, Tammie Benzinger, Erik D. Roberson and Jonathan McConathy
      Journal of Nuclear Medicine February 1, 2022, 63 (2) 287-293; DOI: https://doi.org/10.2967/jnumed.120.254490
  6. Mcconathy, Jonathan

    1. Dynamic Amyloid PET: Relationships to <sup>18</sup>F-Flortaucipir Tau PET Measures
      You have access
      Dynamic Amyloid PET: Relationships to 18F-Flortaucipir Tau PET Measures
      Fabio Raman, Yu-Hua Dean Fang, Sameera Grandhi, Charles F. Murchison, Richard E. Kennedy, John C. Morris, Parinaz Massoumzadeh, Tammie Benzinger, Erik D. Roberson and Jonathan McConathy
      Journal of Nuclear Medicine February 1, 2022, 63 (2) 287-293; DOI: https://doi.org/10.2967/jnumed.120.254490
  7. Mease, Ronnie C.

    1. An Improved <sup>211</sup>At-Labeled Agent for PSMA-Targeted α-Therapy
      You have access
      An Improved 211At-Labeled Agent for PSMA-Targeted α-Therapy
      Ronnie C. Mease, Choong Mo Kang, Vivek Kumar, Sangeeta Ray Banerjee, Il Minn, Mary Brummet, Kathleen L. Gabrielson, Yutian Feng, Andrew Park, Ana P. Kiess, George Sgouros, Ganesan Vaidyanathan, Michael R. Zalutsky and Martin G. Pomper
      Journal of Nuclear Medicine February 1, 2022, 63 (2) 259-267; DOI: https://doi.org/10.2967/jnumed.121.262098
  8. Medina, Sevastian

    1. Diagnostic Performance and Clinical Impact of <sup>68</sup>Ga-PSMA-11 PET/CT Imaging in Early Relapsed Prostate Cancer After Radical Therapy: A Prospective Multicenter Study (IAEA-PSMA Study)
      Open Access
      Diagnostic Performance and Clinical Impact of 68Ga-PSMA-11 PET/CT Imaging in Early Relapsed Prostate Cancer After Radical Therapy: A Prospective Multicenter Study (IAEA-PSMA Study)
      Juliano J. Cerci, Stefano Fanti, Enrique E. Lobato, Jolanta Kunikowska, Omar Alonso, Sevastian Medina, Fuad Novruzov, Thabo Lengana, Carlos Granados, Rakesh Kumar, Venkatesh Rangarajan, Akram Al-Ibraheem, Mukbil Hourani, Nor S. Ali, Azra Ahmad, Zohar Keidar, Ozlem Küçük, Umut Elboga, Mateos Bogoni and Diana Paez
      Journal of Nuclear Medicine February 1, 2022, 63 (2) 240-247; DOI: https://doi.org/10.2967/jnumed.120.261886
  9. Meier, Silvio R.

    1. <sup>11</sup>C-PiB and <sup>124</sup>I-Antibody PET Provide Differing Estimates of Brain Amyloid-β After Therapeutic Intervention
      Open Access
      11C-PiB and 124I-Antibody PET Provide Differing Estimates of Brain Amyloid-β After Therapeutic Intervention
      Silvio R. Meier, Dag Sehlin, Sahar Roshanbin, Victoria Lim Falk, Takashi Saito, Takaomi C. Saido, Ulf Neumann, Johanna Rokka, Jonas Eriksson and Stina Syvänen
      Journal of Nuclear Medicine February 1, 2022, 63 (2) 302-309; DOI: https://doi.org/10.2967/jnumed.121.262083
  10. Meignan, Michel

    1. You have access
      A Guide to ComBat Harmonization of Imaging Biomarkers in Multicenter Studies
      Fanny Orlhac, Jakoba J. Eertink, Anne-Ségolène Cottereau, Josée M. Zijlstra, Catherine Thieblemont, Michel Meignan, Ronald Boellaard and Irène Buvat
      Journal of Nuclear Medicine February 1, 2022, 63 (2) 172-179; DOI: https://doi.org/10.2967/jnumed.121.262464
« Previous (Pages : 1 2 ... 2) Next »
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine: 63 (2)
Journal of Nuclear Medicine
Vol. 63, Issue 2
February 1, 2022
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)

Issue highlights

  • 68Ga-NODAGA-Exendin-4 PET/CT Improves the Detection of Focal Congenital Hyperinsulinism
  • An Improved 211At-Labeled Agent for PSMA-Targeted α-Therapy
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • MIRD Pamphlet No. 28, Part 1: MIRDcalc—A Software Tool for Medical Internal Radiation Dosimetry
  • Absorbed Dose–Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine
  • Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
  • Renal and Multiorgan Safety of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy
  • High-Temporal-Resolution Lung Kinetic Modeling Using Total-Body Dynamic PET with Time-Delay and Dispersion Corrections
More...
SNMMI

© 2025 SNMMI

Powered by HighWire